This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jeet Kalia: Innovator in Neurological Treatments
Introduction
Jeet Kalia is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of neuroscience through his innovative research and patent developments. His work focuses on the inhibition of human voltage-gated sodium channels, which has important implications for treating various neurological disorders.
Latest Patents
Kalia holds a patent for "Derivatives of rufinamide and their use in inhibition of the activation of human voltage-gated sodium channels." This invention provides compounds capable of inhibiting the activation of hNav1.1 or hNav1.6 sodium channels in neurons. The patent outlines pharmaceutical compositions that include these compounds and methods for preventing and treating neurological disorders. These disorders include seizures, Lennox-Gastaut Syndrome, Dravet syndrome, and various anxiety disorders, among others.
Career Highlights
Jeet Kalia is affiliated with Johns Hopkins University, where he conducts his research and development work. His innovative approach to addressing complex neurological issues has garnered attention in the scientific community. Kalia's dedication to improving patient outcomes through his inventions is commendable.
Collaborations
Kalia collaborates with Frank Bosmans, a fellow researcher in the field. Their combined expertise enhances the potential for breakthroughs in neurological treatments.
Conclusion
Jeet Kalia's contributions to the field of neuroscience through his patent and research at Johns Hopkins University highlight his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various neurological disorders.